They reported that anti-VEGF treatment at 6 to 14 days before PPV could significantly improve post-operative BCVA, decrease the incidence of recurrent vitreous hemorrhage, as well as reduce the duration of surgery. Here, VEGFA is linked to vitreous hemorrhage.